Effect of Pycnogenol® on attention-deficit hyperactivity disorder (ADHD): study protocol for a randomised controlled trial

Effect of Pycnogenol® on attention-deficit hyperactivity disorder (ADHD): study protocol for a randomised controlled trial

Abstract Background Methylphenidate (MPH), the first choice medication for attention-deficit hyperactivity disorder (ADHD), is associated with serious adverse effects like arrhythmia. Evidence on the association of ADHD with immune and oxidant-antioxidant imbalances offers potential for antioxidant...

Full description

Bibliographic Details
Main Authors: Annelies A. J. Verlaet, Berten Ceulemans, Helene Verhelst, Dirk Van West, Tess De Bruyne, Luc Pieters, Huub F. J. Savelkoul, Nina Hermans
Format: Article
Language:English
Published: BMC 2017-03-01
Series:Trials
Subjects:
ADHD
ADD
Behaviour
Pycnogenol®
Antioxidant
Polyphenols
Online Access:http://link.springer.com/article/10.1186/s13063-017-1879-6

Internet

http://link.springer.com/article/10.1186/s13063-017-1879-6

Similar Items